JAFL
RVMD icon

Jay A. Fishman Ltd’s Revolution Medicines RVMD Stock Holding History

Jay A. Fishman Ltd’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,000
Closed -$398K – 83
2025
Q4 		$398K Hold
5,000
– – 0.03% 71
2025
Q3 		$234K Buy
+5,000
New +$196K 0.02% 77
2025
Q1 		– Sell
-5,000
Closed -$219K – 87
2024
Q4 		$219K Hold
5,000
– – 0.02% 83
2024
Q3 		$227K Buy
+5,000
New +$218K 0.02% 81

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jay A. Fishman Ltd's RVMD Position: Q1 2026 in Review

Jay A. Fishman Ltd sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 5,000 shares — an estimated $398K sold.

Jay A. Fishman Ltd first reported a position in RVMD in Q3 2024 and held it in 4 quarters. The position peaked at $398K in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Jay A. Fishman Ltd reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 5,000 Revolution Medicines shares in Q1 2026, an estimated $398K.
  • Jay A. Fishman Ltd first reported a position in Revolution Medicines in Q3 2024 and held it in 4 quarters.
  • Jay A. Fishman Ltd's Revolution Medicines position peaked at $398K in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Jay A. Fishman Ltd's 13F filing for Q1 2026, filed 29 Apr 2026.